Hypoxic tumor microenvironment leads to inhibition of miR-326 expression in a HIF1α-dependent manner in cancer cells, in turn, promoting ITGA5 expression and hyperactivation of subsequent integrin signaling, resulting in chemotherapy resistance in TNBC cells (110). The gene discussed is HIF1A; the disease is cancer.